Gene · 3693
Papers1,722
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,722
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma. | Neoplasia | 2023 | 36621024 | PubTator, text mining | PubMed |
| Genetic, DNA methylation, and immune profile discrepancies between early-stage single primary lung cancer and synchronous multiple primary lung cancer. | Clin Epigenetics | 2023 | 36611170 | PubTator, text mining | PubMed |
| Targeting integrin pathways: mechanisms and advances in therapy. | Signal Transduct Target Ther | 2023 | 36588107 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing uncovers dynamic roadmap and cell-cell communication during buffalo spermatogenesis. | iScience | 2023 | 36582818 | PubTator, text mining | PubMed |
| M2-like macrophage-derived exosomes facilitate metastasis in non-small-cell lung cancer by delivering integrin αVβ3. | MedComm (2020) | 2023 | 36582304 | PubTator, text mining | PubMed |
| Single-cell protein profiling defines cell populations associated with triple-negative breast cancer aggressiveness. | Mol Oncol | 2023 | 36550781 | PubTator, text mining | PubMed |
| Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10. | Cancer Lett | 2023 | 36538983 | PubTator, text mining | PubMed |
| Biomimicking Extracellular Vesicles with Fully Artificial Ones: A Rational Design of EV-BIOMIMETICS toward Effective Theranostic Tools in Nanomedicine. | ACS Biomater Sci Eng | 2023 | 36535896 | PubTator, text mining | PubMed |
| Non-coding RNA regulation of integrins and their potential as therapeutic targets in cancer. | Cell Oncol (Dordr) | 2023 | 36512308 | PubTator, text mining | PubMed |
| Robust identification of common genomic biomarkers from multiple gene expression profiles for the prognosis, diagnosis, and therapies of pancreatic cancer. | Comput Biol Med | 2023 | 36502691 | PubTator, text mining | PubMed |
| Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy. | Cancer Gene Ther | 2023 | 36494582 | PubTator, text mining | PubMed |
| CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. | Oncogene | 2023 | 36369321 | PubTator, text mining | PubMed |
| TAGLN2 promotes papillary thyroid carcinoma invasion via the Rap1/PI3K/AKT axis. | Endocr Relat Cancer | 2023 | 36222755 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Integrin-KCNB1 potassium channel complexes regulate neocortical neuronal development and are implicated in epilepsy. | Cell Death Differ | 2023 | 36207442 | PubTator, text mining | PubMed |
| Transcriptomic analysis of pathways associated with ITGAV/alpha(v) integrin-dependent autophagy in human B cells. | Autophagy | 2023 | 36016494 | PubTator, text mining | PubMed |
| Regulatory roles of NAT10 in airway epithelial cell function and metabolism in pathological conditions. | Cell Biol Toxicol | 2023 | 35877022 | PubTator, text mining | PubMed |
| Application of the adverse outcome pathway concept for investigating developmental neurotoxicity potential of Chinese herbal medicines by using human neural progenitor cells in vitro. | Cell Biol Toxicol | 2023 | 35701726 | PubTator, text mining | PubMed |
| Identification and functional characterization of imbalanced osteoarthritis-associated fibronectin splice variants. | Rheumatology (Oxford) | 2023 | 35532170 | PubTator, text mining | PubMed |
| Comparative analysis of thoracic and abdominal aortic aneurysms across the segment and species at the single-cell level. | Front Pharmacol | 2022 | 36703732 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3693/papers?page=13